SALVAGE CHEMOTHERAPY WITH BEVACIZUMAB-IRINOTECAN ASSOCIATION IN RECURRENT/REFRACTORY BRAIN TUMORS IN CHILDREN

被引：0
|
作者：
Schiavetti, A. [1 ]
Varrasso, G. [1 ]
Reale, G. [1 ]
De Grazia, A. [1 ]
Ferrara, E. [1 ]
Paiano, M. [1 ]
Clerico, A. [1 ]
机构：
[1] Univ Roma La Sapienza, I-00185 Rome, Italy
来源：
PEDIATRIC BLOOD & CANCER | 2014年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-145
引用
收藏
页码：S286 / S286
页数：1
相关论文
共 50 条
  • [31] Combination salvage chemotherapy for refractory germ cell tumors
    Nature Clinical Practice Urology, 2007, 4 (3): : 119 - 119
  • [32] SALVAGE CHEMOTHERAPY FOR REFRACTORY GERM-CELL TUMORS
    VOGELZANG, NJ
    KENNEDY, BJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 471 - 471
  • [33] A study of docetaxel and irinotecan in children and young adults with recurrent or refractory Ewing sarcoma family of tumors
    Yoon, Jong Hyung
    Kwon, Mi Mi
    Park, Hyeon Jin
    Park, Seog Yun
    Lim, Kun Young
    Joo, Jungnam
    Park, Byung-Kiu
    BMC CANCER, 2014, 14
  • [34] A study of docetaxel and irinotecan in children and young adults with recurrent or refractory Ewing sarcoma family of tumors
    Jong Hyung Yoon
    Mi Mi Kwon
    Hyeon Jin Park
    Seog Yun Park
    Kun Young Lim
    Jungnam Joo
    Byung-Kiu Park
    BMC Cancer, 14
  • [35] Chronic low-dose chemotherapy for refractory or recurrent brain tumors of childhood
    Yanagisawa, T
    Akiyama, M
    Yokoi, K
    Yuza, Y
    Kato, Y
    Fujisawa, K
    Joki, T
    Ohi, S
    Eto, Y
    NEURO-ONCOLOGY, 2005, 7 (03) : 375 - 375
  • [36] Effectiveness of the bevacizumab-irinotecan regimen in the treatment of recurrent glioblastoma multiforme: Comparison with other second-line treatments without this regimen
    Ruiz-Sanchez, Daniel
    Alaguero Calero, Miguel
    Jose Sastre-Heres, Alejandro
    Iglesias Garcia, Maria Teresa
    Calleja Hernandez, Miguel Angel
    Martinez Martinez, Fernando
    Pena-Diaz, Jaime
    ONCOLOGY LETTERS, 2012, 4 (05) : 1114 - 1118
  • [37] Salvage surgery and reoperation after radiation and chemotherapy for primary brain tumors in children
    Shirane, Reizo
    Hayashi, Toshiaki
    Kumabe, Toshihiro
    Tominaga, Teiji
    NEURO-ONCOLOGY, 2008, 10 (03) : 473 - 473
  • [38] Salvage chemotherapy in patients with recurrent germ cell tumors
    Foldyna, M.
    Abrahamova, J.
    Nepomucka, J.
    Donatova, Z.
    Vorilkova, E.
    Kordikova, D.
    EJC SUPPLEMENTS, 2007, 5 (04): : 309 - 309
  • [39] Bevacizumab-irinotecan versus procarbazine-lomustine-vincristine in recurrent high-grade astrocytomas - retrospective analysis of one center
    Fernandes, C.
    Almeida, D.
    Carvalho, B.
    Costa, A.
    Caeiro, C.
    Osorio, L.
    Linhares, P.
    Castro, L.
    Damasceno, M.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S790 - S791
  • [40] Phase II Study with Bevacizumab Irinotecan Association in Relapsed/Progressed Brain Tumors: A Single Institution Experience
    Schiavetti, A.
    Mollace, M. G.
    Fabrizio, B.
    Paiano, M.
    Dominici, C.
    Varrasso, G.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S455 - S456
12345